Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# Halteres Associates

## Sitemaps

- [XML Sitemap](https://halteresassociates.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Pages

- [Home](https://halteresassociates.com/) - Halteres Associates is passionate about improving global healthcare. We can help create global impact and value by matching medical innovation to market needs.
- [Core Competencies](https://halteresassociates.com/about/core-competencies/) - Halteres Associates professionals have extensive experience in a broad spectrum of expertise, including the development and commercialization of diagnostics, medical devices, therapeutics, research reagents and bioscience tools.
- [Interesting stories in the history of diagnostics video series](https://halteresassociates.com/interesting-stories-in-the-history-of-diagnostics-video-series/) - This Is Only A Test | Video Podcast Episode 3: "Learning to Live with the Fungus Among Us" On the third episode of This Is Only A Test, Mickey Urdea is breaking the mold to talk to you about mold! Mycology, the study of the Kingdom of Fungi, might not get the spotlight as often
- [About](https://halteresassociates.com/about/) - Halteres Associates helps guide the development, commercialization and realization of value for new innovations in diagnostics, health and wellness, and global health.
- [Management Team](https://halteresassociates.com/about/management-team/) - Management Team At Halteres Associates, our leadership team brings deep operational expertise and strategic vision to every engagement. With decades of combined experience across diagnostics (including molecular diagnostics), life sciences, and global health, our partners have helped shape some of the industry's most impactful innovations. Our leadership is defined not just by titles, but by
- [Accolades](https://halteresassociates.com/accolades/) - Accolades 19x Titan Health Awards Winner10x Muse Creative Awards Winner7x Telly Awards Winner3x American Business Awards Winner3x Viddy Awards Winner3x Hermes Creative Awards Winner1x Communication Awards Winner1x Davey Awards Winner "THE POWER OF KNOWING" / "STOP LAB CUTS" for ACLA Video Public Service & Activism Video Technology / Science Video Animation Video Medical View the
- [Resources](https://halteresassociates.com/resources/) - Resources Resources provided by Halteres Associates highlight the thought leadership and deep group expertise our team offers its clients and constituents. Tools for COVID-19 Diagnostics Development and Application Overview of COVID-19 Diagnostic Tools Value Creation Roadmap for Diagnostic Developers COVID-19 Use Case Definitions COVID-19 Use Settings (Storyboards) Diagnostics Reports November 2020 Report on Landscape of
- [Video Production Services](https://halteresassociates.com/video-production-services/) - 19x Titan Health Awards Winner10x Muse Creative Awards Winner7x Telly Awards Winner3x American Business Awards Winner3x Viddy Awards Winner3x Hermes Creative Awards Winner1x Communication Awards Winner1x Davey Awards Winner » Learn more about our awards Halteres Video Production Services One of the most vexing challenges in the business of bioscience is how to communicate dense
- [“Getting Hip to Hepatitis” - Interesting Stories in the History of Diagnostics](https://halteresassociates.com/getting-hip-to-hepatitis-interesting-stories-in-the-history-of-diagnostics/) - Episode 25 of Interesting Stories in the History of Diagnostics - "Getting Hip to Hepatitis" On the first part of this two-part series, Mickey Urdea is sharing his perspective on the discovery of Hepatitis C Virus, and the subsequent impact on global health! Part One covers the earliest work on "Non-A Non-B" Hepatitis at Chiron
- [“Catching Up On Malaria” - Interesting Stories in the History of Diagnostics](https://halteresassociates.com/catching-up-on-malaria-interesting-stories-in-the-history-of-diagnostics/) - Episode 24 of Interesting Stories in the History of Diagnostics - "Catching Up On Malaria" On Episode 24 of Interesting Stories in the History of Diagnostics, Mickey Urdea is buzzing about malaria! Earth's leading mosquito-borne disease affects 247 million people worldwide every year, with about 619,000 deaths. On this episode, Mickey guides you through the
- ["Why Diagnostics Companies Fail: Successes, Failures, and Zombies!"- Interesting Stories in the History of Diagnostics](https://halteresassociates.com/why-diagnostics-companies-fail-successes-failures-and-zombies/) - Episode 23 of Interesting Stories in the History of Diagnostics - "Why Diagnostics Companies Fail: Successes, Failures, and Zombies!" On Episode 23 of "Interesting Stories in the History of Diagnostics", Mickey is resurrecting the idea of the "zombie life science company" to elucidate just why diagnostics companies fail. Some life science companies with a great
- ["Not Staying Mum About Mummies!"](https://halteresassociates.com/not-staying-mum-about-mummies/) - Episode 22 of Interesting Stories in the History of Diagnostics - "Not Staying Mum About Mummies!" While we tend to associate mummies with Halloween, manmade and naturally occurring mummies are one of science's greatest sources of the genetics of human history, and analyzing parasites and diseases within their preserved bodies can help unwrap (if you
- [Celebrating 20 Years of Halteres Associates](https://halteresassociates.com/celebrating-20-years-of-halteres-associates/) - Celebrating 20 Years of Halteres Associates:A Celebration, A Retrospective, and What's Next At Halteres Associates, we are celebrating our 20th Anniversary, and we want to acknowledge and thank our many constituents around the world for their support and allowing us to assist them with their innovations. When we started Halteres Associates, we had no idea
- [“Getting Crispy About CRISPR!”  Interesting Stories In The History Of Diagnostics](https://halteresassociates.com/getting-crispy-about-crispr-interesting-stories-in-the-history-of-diagnostics/) - Episode 21 of Interesting Stories in the History of Diagnostics - "Getting Crispy About CRISPR!" On episode 21 of "Interesting Stories In The History Of Diagnostics", Mickey Urdea is asking: "Are we not drawn onward, we few, drawn onward to new era?" That's no puzzle - it's a palindrome! Yes that's right, he's discussing CRISPR,
- [“How The Plague Played Out!”,  Interesting Stories In The History Of Diagnostics](https://halteresassociates.com/episode-20-of-interesting-stories-in-the-history-of-diagnostics-how-the-plague-played-out/) - Episode 20 of Interesting Stories in the History of Diagnostics -"How The Plague Played Out!" On this episode, Mickey Urdea is plunging into the plague! The bubonic plague pandemic, or The Black Death, caused by the bacterium Yersinia pestis, was the most fatal pandemic recorded in human history, killing at least 75-200 million people and
- [News & Events](https://halteresassociates.com/about/news-events/) - News & Events 2023 March 7, 2023 Halteres Associates Launches Halteres Presents Podcast Series Exclusive Interviews with Experts in the Diagnostics Field to Bolster the Global Dialogue on Diagnostic & Life Science Matters SAN RAMON, Calif.--(BUSINESS WIRE)--Halteres Associates, a leading bioscience consultancy that provides strategic and tactical services in the areas of diagnostics, medical devices, and life
- [Episode 19 "Getting To The Bottom Of Cancer!" Parts One - Three](https://halteresassociates.com/episode-19-getting-to-the-bottom-of-cancer-parts-1-3/) - Episode 19 (Part One): "Getting To The Bottom Of Cancer!" In Part 1 on this subject, Mickey tracks cancer all the way from Australopithecus bones and Egyptian mummies up to cutting edge modern day protein assays for the detection of cancer markers for potential uses in early detection, secondary screening, therapy selection, recurrence, and beyond,
- [“Getting To The Bottom of Cancer!”, Part Three - Interesting Stories in the History of Diagnostics](https://halteresassociates.com/getting-to-the-bottom-of-cancer-part-three-interesting-stories-in-the-history-of-diagnostics/) - Episode 19 (Part 3) of Interesting Stories in the History of Diagnostics - "Getting To The Bottom of Cancer!", Part 3 of "Getting To The Bottom of Cancer!", our survey of oncological diagnostics! Episode 1 in this series focused on the history of cancer in recorded history, and now Mickey Urdea gets to move on
- [“Getting To The Bottom of Cancer!”, Part Two - Interesting Stories in the History of Diagnostics](https://halteresassociates.com/getting-to-the-bottom-of-cancer-part-two-interesting-stories-in-the-history-of-diagnostics/) - Episode 19 (part 2) of Interesting Stories in the History of Diagnostics - "Getting To The Bottom of Cancer!", Part 2 of "Getting To The Bottom of Cancer!", our survey of oncological diagnostics! Episode 1 in this series focused on the history of cancer in recorded history, and now Mickey Urdea gets to move on
- [Report on Landscape of Companies for Influenza Tests](https://halteresassociates.com/report-on-landscape-of-companies-for-influenza-tests/) - Report on Landscape of Companies for Influenza Tests (November 2020) By Halteres Associates Diagnostics are a fundamental component of successful epidemic and pandemic control strategies. The SARS-CoV-2 pandemic has highlighted on a grand scale the barriers to diagnostic preparedness that are common to all outbreaks, and perhaps has created a unique moment when the commercial,
- [Stop Lab Cuts](https://halteresassociates.com/stop-lab-cuts/) - Stop Lab Cuts Halteres Associates has partnered with the American Clinical Laboratories Association (ACLA) on a series of animated videos for the national trade organization's "Stop Lab Cuts" campaign. The "Stop Lab Cuts" campaign helped secure a one-year reprieve from both Medicare (PAMA) payment cuts of up to 15 percent to over 800 laboratory services
- [Episode 18 "Don't Hold Your Breath!"](https://halteresassociates.com/episode-18-dont-hold-your-breath/) - Episode 18: "Don't Hold Your Breath!" On Episode 18 of "Interesting Stories in the History of Diagnostics", Mickey Urdea is reviewing breath-based diagnostics, or what is transpiring with transpiration! Exhaled breath holds many secrets beyond what you ate for breakfast, and analysis of the compounds in breath can help to diagnose SARS-CoV-2, gastrointestinal disorders, and
- [Episode 17 "Not a Drop of Truth: The Impossible Promise of Theranos"](https://halteresassociates.com/episode-17-not-a-drop-of-truth-the-impossible-promise-of-theranos/) - Episode 17: "Not a Drop of Truth: The Impossible Promise of Theranos" On October 17th, 2022, Elizabeth Holmes, the disgraced founder of the now-bankrupt diagnostics company Theranos, will be sentenced after her conviction for one count of wire fraud conspiracy and three substantive wire fraud counts relating to the scheme to defraud investors, including wire
- [Episode 16 The Clock Is Ticking On Tick-Borne Disease](https://halteresassociates.com/the-clock-is-ticking-on-tick-borne-disease/) - Episode 16: "The Clock Is Ticking On Tick-Borne Diseases!" Tick tock, it's time for some tick talk! On this episode, Mickey is discussing tick-borne diseases - their causes, their related detection technologies, and why climate change might exacerbate the problem worldwide. Lyme Disease receives much of the spotlight (especially given its many famous cases, including
- [Terms of Use](https://halteresassociates.com/terms-of-use/) - Terms of Use Ownership of Site; Agreement to Terms of Use These Terms and Conditions of Use (the "Terms of Use") apply to the Halteres Associates web site located at www.halteresassociates.com, and all associated sites linked to www.halteresassociates.com by Halteres Associates (collectively, the "Site"). The Site is the property of Halteres Associates Inc. ("Halteres Associates") and its licensors.
- [Episode 15: “Waste Not, Want Not, With Wastewater!”](https://halteresassociates.com/episode-15-waste-not-want-not-with-wastewater/) - Episode 15: "Waste Not, Want Not, With Wastewater!" This week, we're getting to the very last drop on the subject of wastewater testing! Hot in the news after recent occurrences of polio and monkeypox, as well as for the continued monitoring of Covid-19, wastewater testing is the future of public health monitoring. Breakthroughs in wastewater
- [Global Health/NGOs](https://halteresassociates.com/global-health-ngos/) - Global Health / NGOs Halteres Associates has an unbridled passion for global health, and our relationships in the global health community allow us to bolster non-governmental organizations' ability to provide quality diagnostic testing worldwide. Our team possesses decades of experience in global health, and can help non-governmental organizations make the greatest impact possible in areas
- [Startups](https://halteresassociates.com/startups/) - Startups Halteres Associates helps strengthen public and private biotech startups at all phases in their development, by alerting them of potential landmines ahead, guiding them through their fundraising stages, and more. Our individual project-based approach allows our curated team of experts to provide the highest quality, most specific insights into matters of technology, development, marketing, business
- [Investors](https://halteresassociates.com/investors/) - Investors Halteres Associates assists investment firms and venture capital groups in deciding what technologies and companies to invest in, and which to avoid. Our experienced team understands the vital role that investment plays in emerging diagnostics and biomedical advances, and our passion for innovation in the sector means protecting investments and advocating for worthy, profitable technologies.
- [Multinational Corporations](https://halteresassociates.com/multinational-corporations/) - Multinational Corporations Halteres Associates brings their industry expertise to companies working in diagnostics, pharmaceuticals, medical devices, instrumentation, new technologies, and other emerging markets to help them expand their offerings and solidify the offerings they have. The Halteres team hand selects experts for each project, which allows us to assist multinational corporations on a wide variety of
- [Home Alt2](https://halteresassociates.com/home-alt2/) - HALTERES ASSOCIATES Helping transform medical discovery and innovation into viable solutions that can impact the world Global Health » Read More About Our Global Health Partnerships Start Ups » Read More About Our Work With Start Ups & Entrepreneurs Multinational Corporations » Read More About How We Engage With Global Business Investors » Read More
- [Newsletter Signup](https://halteresassociates.com/newsletter-signup/) - Sign up for our Newsletter Your privacy is important to us.
- [Child Safeguarding Statement](https://halteresassociates.com/child-safeguarding-statement/) - Child Safeguarding Statement This statement applies to all Halteres Associates, LLC, (Halteres) staff, including employees, anyone working on the behalf of Halteres and its consultants. The purpose of this statement is to acknowledge the protection of children who are directly influenced by Halteres' services. This includes the children of adults who use our service. A
- [Privacy Policy](https://halteresassociates.com/privacy-policy/) - Halteres Privacy Policy Effective Date: November 9, 2018 Halteres Associates LLC ("us", "we", or "our") owns the website located at http://www.halteresassociates.com (the "Site"). This page informs you of our policies regarding the collection, use and disclosure of Personal Information we receive from users of the Site. We know that you care how information about you
- [Contact](https://halteresassociates.com/contact/) - Contact Halteres CONTACT DETAILS Halteres Associates, LLC 2010 Crow Canyon Place Suite 100 San Ramon, CA 94583 Email: info@halteresassociates.com CONNECT WITH US LET'S GET IN TOUCH Name(Required) Your Email(Required) PhoneMessageWho would you like to reach?(Required)Choose OneMickeyRichGeneralVideo Productions
- [Point of Care Testing](https://halteresassociates.com/focus-areas/point-of-care-testing/) - Increased Interest in Point of Care Testing: What's Changed? The primary driver of point of care testing is the need for real time actionable results, thereby facilitating linkage to care. Convenience, while important, is seldom a sufficient market or revenue driver on its own. Challenge Linkage to care, as evidenced by improvements in medical, health
- [Delivering Diagnostics for Global Health](https://halteresassociates.com/focus-areas/delivering-diagnostics-for-global-health/) - Delivering Diagnostics for Global Health Diagnostic tests are an integral part of health care in the developed world, but access to appropriate diagnostics in developing countries is constrained by incomplete solutions. Challenge Only an estimated 45% of those who need testing in sub-Saharan Africa get it. Implementing sustainable diagnostics in resource limited settings requires understanding
- [The Role of Impact Modeling](https://halteresassociates.com/focus-areas/the-role-of-impact-modeling/) - Establishing the "Value" in High Value Diagnostics - The Role of Impact Modeling Complexity or elegance in design or performance of a new diagnostic test does not automatically translate into the perceived value of the results. Challenge Companion diagnostics and multivariate tests are driving expanded interest in diagnostics, but demonstration of value and realization of
- [Portfolio Planning](https://halteresassociates.com/focus-areas/portfolio-planning/) - Portfolio Planning Companies wishing to compete successfully in clinical diagnostics must compare and balance the technical difficulty of developing, delivering and supporting a new set of clinical diagnostic products with the potential financial return offered by those products. © 2018 Halteres Associates LLC Challenge Succeeding in the clinical diagnostics business requires the focused application of
- [Maximizing Value](https://halteresassociates.com/focus-areas/maximizing-value/) - Maximizing the Value of Your Product or Service: Understanding Market Needs Companies wishing to compete successfully in the clinical diagnostics market must first gain a deep understanding of key stakeholders and the needs of the market that they plan to serve. © 2018 Halteres Associates LLC Challenge Succeeding in the clinical diagnostics business requires technological
- [Focus Areas](https://halteresassociates.com/focus-areas/) - Halteres Focus Areas: Overview Halteres team members are based throughout the world (North and South America, Europe, Asia and Africa) and have operating experience in companies and organizations of all sizes. Our clients have ranged from small two to three person startups to large multinational companies such as Roche, Siemens and General Electric to non-profit
- [Our Clients](https://halteresassociates.com/our-constituencies/our-clients/) - Our Clients Halteres Associates serves a wide range of clients, from small start-ups to large multi-national corporations and global non-profit organizations, spanning a broad constituency base working in life sciences, technologies and global health. Following is a partial alphabetical listing of our clients: 5AM Ventures Achaogen, Inc. Aclara Biosciences, Inc. Adamas Pharmaceuticals, Inc. Advanced Cell Diagnostics,
- [Tools for COVID-19 Diagnostic Development and Application](https://halteresassociates.com/tools-for-covid-19-diagnostic-development-and-application/) - Tools for COVID-19 Diagnostic Development and Application Resources provided by Halteres Associates to our clients and constituents to assist them in developing or identifying the best products to fill specific market needs Since the outbreak of COVID-19, we have been preparing a series of newsletters providing information about SARS-CoV-2 medical tests. We began with a
- [Value Creation Roadmap for Diagnostic Developers](https://halteresassociates.com/value-creation-roadmap-for-diagnostic-developers/) - Value Creation Roadmap for Diagnostic Developers An overview of how the definition of Use Cases, Use Settings (story boards), and Target Product Profiles are used in the value creation process for diagnostic products Back to COVID-19 Tools Designing Products to Facilitate Actions: The Value Creation Roadmap As product developers, we have all had high hopes
- [Episode 14 - “The Physician Who Knows Syphilis Knows Medicine!”](https://halteresassociates.com/episode-14-the-physician-who-knows-syphilis-knows-medicine/) - Episode 14: "The Physician Who Knows Syphilis Knows Medicine!" In the next installment of "Interesting Stories in the History of Diagnostics", Mickey Urdea is catching you up on syphilis, the evolution of its symptoms and treatment over seven centuries, and the still hotly-debated subject of whether "the great pox" was originally an Old World or
- [Episode 13 - “This Wormy World!” Part Two – An Interview with Govert Van Dam](https://halteresassociates.com/episode-13-this-wormy-world-part-two-an-interview-with-govert-van-dam/) - Episode 13: "This Wormy World!" Part Two - An Interview with Govert Van Dam Dr. Mickey Urdea doesn't want to stir up a can of worms, but he's returning to "This Wormy World"! On this episode, Dr. Urdea gets the opportunity to interview Dr. Govert Van Dam, a Senior Researcher for the Leiden Parasitology Diagnostics
- [Episode 12 - “Feeling Nutsy for Ötzi!” - Interesting Stories in the History of Diagnostics](https://halteresassociates.com/episode-12-feeling-nutsy-for-otzi-interesting-stories-in-the-history-of-diagnostics/) - Episode 12 "Feeling Nutsy for Ötzi!" "Ötzi the Iceman was a jolly happy soul…" Today, Mickey Urdea is discussing Ötzi the Iceman, the natural mummy discovered by accident in 1991 frozen atop the Ötztal Alps between Austria and Italy (which is, of course, how he got his nickname). Besides being the oldest natural mummy of the
- [Copy of Home](https://halteresassociates.com/home-copy/) - Halteres Associates is passionate about improving global healthcare. We can help create global impact and value by matching medical innovation to market needs.
- [Episode 11 of Interesting Stories in the History of Diagnostics – “Going With The Lateral Flow!”](https://halteresassociates.com/episode-11-of-interesting-stories-in-the-history-of-diagnostics-going-with-the-lateral-flow/) - Episode 11 of Interesting Stories in the History of Diagnostics - "Going With The Lateral Flow!" On this episode, Mickey Urdea is going with the flow - the lateral flow! The most commonly known type of lateral flow assay is the pregnancy test, but now with self-tests for Covid-19, LFAs are more popular than ever!
- [Episode 10 of Interesting Stories in the History of Diagnostics – "You Must Be Pollen My Leg!”](https://halteresassociates.com/episode-10-of-interesting-stories-in-the-history-of-diagnostics-you-must-be-pollen-my-leg/) - Episode 10 of Interesting Stories in the History of Diagnostics - "You Must Be Pollen My Leg!" On this week's episode, Dr. Mickey Urdea is reviewing palynology, the study of grain, pollen, and other spores, and its use in forensics! Dr. Urdea covers how palynology has been used (or underused) in the 20th century, and
- [Episode 9 of Interesting Stories in the History of Diagnostics – "Weighing In On The Biggest Loser!"](https://halteresassociates.com/episode-9-of-interesting-stories-in-the-history-of-diagnostics-weighing-in-on-the-biggest-loser/) - Episode 9 of Interesting Stories in the History of Diagnostics - "Weighing In On The Biggest Loser!" This week, Dr. Mickey Urdea is weighing in on the reality TV show, "The Biggest Loser"! Having collaborated with the chief medical officer for three seasons of the show's run, Mickey provides a unique perspective on the science
- [Episode 8 of Interesting Stories in the History of Diagnostics – “Do We Have a Quorum?"](https://halteresassociates.com/episode-8-of-interesting-stories-in-the-history-of-diagnostics-do-we-have-a-quorum/) - Episode 8 of Interesting Stories in the History of Diagnostics - "Do We Have a Quorum?" In this episode, Dr. Mickey Urdea asks, "Do we have a quorum?" Quorum sensing, that is! Gather round by the light of the bobtail squid to learn more about this phenomenon which allows certain bacteria to "think" collectively as
- [Episode 7 of Interesting Stories in the History of Diagnostics - “Going Viral With Viral Load!”](https://halteresassociates.com/episode-7-of-interesting-stories-in-the-history-of-diagnostics-going-viral-with-viral-load/) - Episode 7 of Interesting Stories in the History of Diagnostics - "Going Viral With Viral Load!" Today, Dr. Mickey Urdea gets to discuss his own achievements as the inventor of "viral load", or the quantitative measure of viral RNA, and as the leader of the team at Chiron Corporation to first utilize this method in
- [Episode 6 of Interesting Stories in the History of Diagnostics - “Within Spitting Distance of Saliva!”](https://halteresassociates.com/episode-6-of-interesting-stories-in-the-history-of-diagnostics-within-spitting-distance-of-saliva/) - Episode 6 of Interesting Stories in the History of Diagnostics - "Within Spitting Distance of Saliva!" In episode 6, we're not reading tea leaves - we're reading saliva! Saliva is a particularly interesting series of compounds that can tell a surprisingly detailed story of a person's health, and it can be used to test for
- [Episode 5 of Interesting Stories in the History of Diagnostics –  “A • B • C • D • eDNA!”](https://halteresassociates.com/episode-5-of-interesting-stories-in-the-history-of-diagnostics-a-b-c-d-edna/) - Episode 5 of Interesting Stories in the History of Diagnostics - "A • B • C • D • eDNA!" This week, Dr. Mickey Urdea is exploring eDNA, or environmental DNA, and its uses and applications in diagnostics! Tune in to hear about wastewater testing, just how much DNA can be found outside of a zoo,
- ["Can't Live With 'Em, Can't Live Without 'Em!" Part One- Interesting Stories in the History of Diagnostics](https://halteresassociates.com/cant-live-with-em-cant-live-without-em-part-one-interesting-stories-in-the-history-of-diagnostics/) - Episode 4 of Interesting Stories in the History of Diagnostics - "Can't Live With 'Em, Can't Live Without 'Em!" Part One" In this two-part episode of Interesting Stories in the History of Diagnostics, Dr. Mickey Urdea is discussing bacteria, and why we "Can't Live With 'Em, Can't Live Without 'Em!" Part One of this two-part
- [Diagnostics Industry Insights Video Series](https://halteresassociates.com/diagnostics-industry-insights-video-series/) - Diagnostics Industry Insights Series Episode 1 - "The Diagnostics Industry in the Post-Pandemic World" In this installment of our "Diagnostics Industry Insights" series, managing partner Rich Thayer makes four observations about changes to the diagnostics industry in the post-pandemic world - new competitors entering the marketplace, increased awareness of diagnostics, expanded manufacturing capacity, and pandemic
- ["Can't Live With 'Em, Can't Live Without 'Em!" Part Two - Interesting Stories in the History of Diagnostics](https://halteresassociates.com/cant-live-with-em-cant-live-without-em-part-two-interesting-stories-in-the-history-of-diagnostics-2/) - Episode 5 of Interesting Stories in the History of Diagnostics - "Can't Live With 'Em, Can't Live Without 'Em!" Part Two In Part Two of Dr. Mickey Urdea's foray into the history of bacteria, the focus is on the history of bacterial culture, sequencing, and amplification methods, and how those developments changed how we diagnose
- [This Wormy World - Interesting Stories in the History of Diagnostics](https://halteresassociates.com/this-wormy-world-interesting-stories-in-the-history-of-diagnostics/) - Episode 3 of Interesting Stories in the History of Diagnostics - "This Wormy World!" In the third episode of our "Interesting Stories in the History of Diagnostics" series, Dr. Mickey Urdea expounds on the history of diseases caused by helminths - aka parasitic worms! Helminth diseases still affect more than 1.5 billion people worldwide (24%
- [PIVOT TO VIDEO](https://halteresassociates.com/pivot-to-video/) - PIVOT TO VIDEO: ON THE ORIGIN OF VIEWS BY MEANS OF VIDEO, OR THE PRESERVATION OF FAVOURED COMPANIES IN THE STRUGGLE FOR ENGAGEMENT - AND WHAT THAT MEANS FOR THE DIAGNOSTICS INDUSTRY Pivoting to video is a hazard-filled proposition. In the mid-2010s, some media companies, most notably Facebook, transitioned to a more video-focused approach to
- [Diagnostics Industry Insights - "The Diagnostics Industry in the Post-Pandemic World"](https://halteresassociates.com/diagnostics-industry-insights-the-diagnostics-industry-in-the-post-pandemic-world/) - Diagnostics Industry Insights - "The Diagnostics Industry in the Post-Pandemic World"
- [What the Nose Knows - Interesting Stories in the History of Diagnostics](https://halteresassociates.com/interesting-stories-in-the-history-of-diagnostics-what-the-nose-knows/) - In this installment of our "Interesting Stories in the History of Diagnostics" series, Dr. Mickey Urdea chronicles the history of the use of smell in diagnostics, from Hippocrates to present day cancer-sniffing dogs (yes, really!). Click here to see the rest of the series "Interesting Stories in the History of Diagnostics"
- [About Halteres Associates | Video Series](https://halteresassociates.com/about-halteres-associates-video-series/) - About Halteres Associates | Video Series An interview with co-founder Mickey Urdea on what makes Halteres Associates such a valuable bioscience consulting asset. Halteres Associates now offers a boutique video production studio
- [Who is Halteres Associates | A Video](https://halteresassociates.com/who-is-halteres-associates-a-video/) - Who is Halteres Associates | A Video An interview with co-founder Mickey Urdea on what makes Halteres Associates such a valuable bioscience consulting asset. Click here to learn more about the management team. Click here to see the series of videos about Halteres Associates
- [Interesting Stories in the History of Diagnostics - The Dynamizer](https://halteresassociates.com/interesting-stories-in-the-history-of-diagnostics-the-dynamizer/) - Interesting Stories in the History of Diagnostics - The Dynamizer In this installment of our "Interesting Stories in the History of Diagnostics" series, Dr. Mickey Urdea shares the story of the Dynamizer, a diagnostic device from the early 20th century which parallels the rise and fall of a more modern example - Theranos. Click here
- [Client Produced Video | Vera Cloud Testing Platform - Nasal Swab Instructions for Use](https://halteresassociates.com/client-produced-video-vera-cloud-testing-platform-nasal-swab-instructions-for-use/) - Client Produced Video | Vera Cloud Testing Platform - Nasal Swab Instructions for Use Click here to see other Halteres Associates client produced videos
- [Series for Halteres Associates Video Production Projects](https://halteresassociates.com/series-for-halteres-associates-video-production-projects/) - Series for Halteres Associates Video Production Projects
- [Medical Device Playbook by StarFish Medical - How to Predict Dx Device Success](https://halteresassociates.com/medical-device-playbook-by-starfish-medical-how-to-predict-dx-device-success/)
- [Storyboard H: Workplace SCREENING of Individuals On-Site for Non-symptomatic Infection](https://halteresassociates.com/storyboard-h/) - Storyboard H: Workplace SCREENING of Individuals On-Site for Non-symptomatic Infection Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description Storyboard H is related to a new Use Case 11, which we have called Screening of Non-Symptomatic Individuals. There has been a great deal of discussion in many quarters
- [Halteres SARS-CoV-2 Use Case Tables](https://halteresassociates.com/halteres-sars-cov-2-use-case-tables/) - Use Cases for SARS-CoV-2 Assays Prepared by Halteres Associates, September 15, 2020 Download Word .doc Back to COVID-19 Tools Use Case 1 | Use Case 2 | Use Case 3 | Use Case 4 | Use Case 5 | Use Case 6 | Use Case 7 | Use Case 8 | Use Case 9 |
- [COVID-19 Use Settings (Storyboards)](https://halteresassociates.com/covid-19-use-settings-storyboards/) - COVID-19 Use Settings (Storyboards) Back to COVID-19 Tools Developing detailed descriptions of Use Settings can be a valuable tool for attaining a deeper understanding of product requirements In order to assist test developers and users, Halteres has developed a series of Storyboards, to help envision possible settings and processes for the use of products defined
- [SARS-COV-2 Use Cases](https://halteresassociates.com/sars-cov-2-use-cases/) - Sign up for COVID-19 Resource Updates SARS-CoV-2 Use Cases White Paper Mickey Urdea, Halteres AssociatesAugust 12, 2020 Download PDF INTRODUCTION The COVID-19 pandemic is now nearly eight months old, and far from over. The global healthcare community has mounted an unprecedented response with scores of vaccine development programs, over 1,000 antiviral drug clinical trials in
- [Consumer Digital and Mobile Health](https://halteresassociates.com/focus-areas/consumer-digital-and-mobile-health/) - We Live in a Digital World: Consumer Digital and Mobile Health Applications Knowing when design attributes of digital health products for wellness and fitness applications are likely to raise the interest of regulatory bodies such as the FDA. Challenge Understanding the regulatory, payment and education challenges, as well as the device and diagnostic product opportunities,
- [The Role of Informatics in Molecular Medicine](https://halteresassociates.com/focus-areas/the-role-of-informatics-in-molecular-medicine/) - The Role of Informatics in Molecular Medicine Utilization of multi-methodology algorithms in medical practice today: The case for integrating diverse diagnostics information to optimize linkage to care. © 2014 Halteres Associates LLC Challenge Achieving success in clinical diagnostics can require integration of in vitro and in vivo testing methodologies, complex panels of assays, data algorithms and IT solutions supporting
- [Our Constituencies](https://halteresassociates.com/our-constituencies/) - Our Constituencies Halteres’ Constituencies span the spectrum of companies, institutions and organizations working to transform medical and global health practices through new discoveries and innovations. Non-government organizations (NGOs) Investment firms Venture capital groups Universities Reference labs Companies working in emerging markets Diagnostics companies Pharmaceutical companies Medical device companies Instrumentation companies Technology companies Start-up, investment stage,
- [Our Philosophy](https://halteresassociates.com/about/our-philosophy/) - Our Philosophy We are committed to client success, and ask ourselves: “If we were the management team of this organization, what would we need to know to make good decisions?” We are passionate about improving global healthcare and the practice of medicine, pursuing solutions that resolve unmet needs and improve accessibility for everyone. We form customized
- [Storyboard I: At-Home Sample Collection for Lab-Based Testing](https://halteresassociates.com/storyboard-i/) - Storyboard I: At-Home Sample Collection for Lab-Based Testing Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description Storyboard I is based upon the use of samples collected at home instead of by a healthcare professional. Upon collection, the samples are packaged and delivered for shipment and off-site testing.
- [Storyboard G: Population Surveillance Testing for Current Infection and/or Prior Exposure](https://halteresassociates.com/storyboard-g/) - Storyboard G: Population Surveillance Testing for Current Infection and/or Prior Exposure Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description Storyboard G is envisioned for Use Case 8, which has been modified from our previous version that was first published in April 2020. Use Case 8 now illustrates
- [Storyboard F: DIFFERENTIAL DIAGNOSTIC Test Off-Site in Endemic Setting (Mild to Moderate)](https://halteresassociates.com/storyboard-f/) - Storyboard F: DIFFERENTIAL DIAGNOSTIC Test Off-Site in Endemic Setting (Mild to Moderate) Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description The second Use Setting (Storyboard) for Use Case 6 is quite similar to Storyboard D, with the same changes in Step M to a new set of
- [Storyboard E: Point of Care Rapid DIFFERENTIAL DIAGNOSTIC in Epidemic Setting](https://halteresassociates.com/storyboard-e/) - Storyboard E: Point of Care Rapid DIFFERENTIAL DIAGNOSTIC in Epidemic Setting Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description Like Use Case 5, we have envisioned two Use Settings (Storyboards) for our Use Case 6: one for the point-of-care diagnostic setting (on-site testing; Storyboard E) and one
- [Storyboard D: DIAGNOSIS of symptomatic individuals in endemic setting with send-out lab test](https://halteresassociates.com/storyboard-d/) - Storyboard D: DIAGNOSIS of symptomatic individuals in endemic setting with send-out lab test Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description The second Storyboard for Use Case 5 is quite similar to Storyboard B. The significant differences include changes to a number of Steps due to the
- [Storyboard C: DIAGNOSIS of symptomatic individuals in epidemic settings with POC testing](https://halteresassociates.com/storyboard-c/) - Storyboard C: DIAGNOSIS of symptomatic individuals in epidemic settings with POC testing Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description We have envisioned two Use Settings (storyboards) for our Use Case 5: one setting for the point-of-care diagnostic setting (on-site testing; Storyboard C) and one setting for
- [Storyboard B: CONFIRMATORY DIAGNOSTIC Test Off-Site (Mild to Moderate symptoms)](https://halteresassociates.com/storyboard-b/) - Storyboard B: CONFIRMATORY DIAGNOSTIC Test Off-Site (Mild to Moderate symptoms) Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description Storyboard B, which aligns with our Use Case 4, begins from O1 in Storyboard A, where the patient must wait for the results of an offsite confirmation test result.
- [Storyboard A:  TRIAGE of symptomatic individuals in epidemic setting](https://halteresassociates.com/storyboard-a/) - Storyboard A: TRIAGE of symptomatic individuals in epidemic setting Back to Storyboards Download PDF Subscribe for Updates Preview modal- Description Observations & Implications Legend Description Storyboard A represents a triage setting described in our Use Cases 1 and 2, where a triage test is performed to capture most of the positive samples with a simple,
- [COVID Updates Form](https://halteresassociates.com/covid-19-updates-form/)
- [Primum Non Nocere: Is the Performance of Available SARS-CoV-2 RNA and Immunoassays Good Enough To Do No Harm?](https://halteresassociates.com/primum-non-nocere-is-the-performance-of-available-sars-cov-2-rna-and-immunoassays-good-enough-to-do-no-harm/) - Primum Non Nocere: Is the Performance of Available SARS-CoV-2 RNA and Immunoassays Good Enough To Do No Harm? April 14, 2020 We have appreciated the conversation of the last few days amongst the AACC Artery community. So many of you struggle to provide the COVID-19 testing that your constituencies desire and need. We have been
- [COVID-19 Diagnostic Use Cases](https://halteresassociates.com/covid-19-diagnostic-use-cases/) - COVID-19 Diagnostic Use Cases March 20, 2020 Download Word .doc INTRODUCTION In December 2019, astute physicians noted an unknown pneumonia in Wuhan, China. It was soon recognized as a new pathogen, a previously undetected coronavirus, reminiscent of SARS-CoV (cause of SARS) and MERS-CoV (cause of MERS). The WHO has named the new coronaviral disease COVID-19,
- [Use Cases for SARS-CoV-2 Assays](https://halteresassociates.com/use-cases-for-sars-cov-2-assays/) - Use Cases for SARS-CoV-2 Assays Prepared by Halteres Associates, March 25, 2020 Use Case 1 | Use Case 2 | Use Case 3 | Use Case 4 | Use Case 5 | Use Case 6 | Use Case 7 | Use Case 8 | Use Case 9 Use Case 1: Triage of symptomatic individuals in
- [Use Cases for SARS-CoV-2 Assays 2](https://halteresassociates.com/use-cases-for-sars-cov-2-assays-2/) - Use Cases for SARS-CoV-2 Assays Prepared by Halteres Associates, March 20, 2020 Use Case 1: Triage of symptomatic individuals in an epidemic setting Description Other Possible Technologies Required Samples Comments The intended use is to determine if a symptomatic individual in an epidemic setting has a reasonable likelihood of a current infection warranting temporary isolation
- [Cookie Policy](https://halteresassociates.com/cookie-policy/) - This site uses cookies - small text files that are placed on your machine to help the site provide a better user experience. In general, cookies are used to retain user preferences, store information for things like shopping carts, and provide anonymised tracking data to third party applications like Google Analytics. As a rule, cookies
- [Learn More About](https://halteresassociates.com/learn-more-about/)

## Site Builder

- [GTM-Body](https://halteresassociates.com/astra-advanced-hook/gtm-body/)
- [GTM](https://halteresassociates.com/astra-advanced-hook/gtm/)
- [Inside page banner](https://halteresassociates.com/astra-advanced-hook/inside-page-banner/)
- [CTA bottom](https://halteresassociates.com/astra-advanced-hook/cta-bottom/) - Sign Up for Our Newsletter Contact Halteres Associates